Amyloid‐Related Imaging Abnormality (ARIA) Beyond the APOE‐ε4 Allele

Besin, Valentinus and Humardani, Farizky Martriano and Yudiarto, Fenny Lanawati and Ong, Paulus Anam and Putra, Sulistyo Emantoko Dwi and Ningrum, Ratih Asmana (2025) Amyloid‐Related Imaging Abnormality (ARIA) Beyond the APOE‐ε4 Allele. Chronic Diseases and Translational Medicine. ISSN 2589-0514; E-ISSN:2095-882X

PDF Sulistyo Emantoko_Amyloid-Related Imaging Abnormality.pdf Download (2MB)

Abstract

Monoclonal antibodies (mAbs) have made significant progress in the treatment of Alzheimer's disease (AD). However, mAbs are associated with adverse effects, including Amyloid‐Related Imaging Abnormality (ARIA), which manifests as edema or effusion (ARIA‐E) and hemorrhage (ARIA‐H). The mechanisms behind these effects are not yet fully understood. Moreover, spontaneous ARIA has been insufficiently explored, and mAb therapies, particularly lecanemab, have mainly focused on patients with the APOE‐ε4 allele carrier. This review aims to address this gap by examining the mechanisms of spontaneous ARIA, ARIA induced by mAbs, and the influence of genetic variants on ARIA development. The autoantibody‐Aβ‐mediated immune response targets excessive Aβ deposits, increasing immune activity through microglial reactivity. The heightened immune response, driven by Aβ accumulation in blood vessels, promotes angiopathy and inflammation, potentially con- tributing to spontaneous ARIA. The APOE‐ε4 allele carrier is more strongly associated with ARIA‐E because it redistributes Aβ deposition from the brain to blood vessels, influencing microglial reactivity. The redistribution enhances vascular integrity and reduces the risk of ARIA‐H. However, it also increases the likelihood of ARIA‐E due to Aβ accumulation in the vasculature, triggering inflammation. In contrast, the development of ARIA‐H is linked to increased TREM2 expression and microglial reactivity, leading to impaired vascular integrity and disrupted matrix remodeling, which worsens the condition. Additionally, the adverse effects of mAbs may extend beyond the APOE‐ε4 allele, possibly impacting other genetic variants involved in microglial reactivity, Aβ redistribution, and vascular integrity.

Item Type:	Article
Uncontrolled Keywords:	Alzheimer's disease; amyloid‐related imaging abnormalities; | monoclonal antibodies
Subjects:	R Medicine > R Medicine (General)
Divisions:	Faculty of Medical
Depositing User:	Ester Sri W. 196039
Date Deposited:	28 Apr 2025 09:22
Last Modified:	30 Apr 2025 04:46
URI:	http://repository.ubaya.ac.id/id/eprint/48434

Actions (login required)

View Item